Alzheimer’s Benefits May Continue After Donanemab Treatment Ends, Data Suggest
(MedPage Today) — New data suggested that donanemab (Kisunla) sustained long-term benefits after a limited dosing period in a subgroup of people with early symptomatic Alzheimer’s disease.
Early Alzheimer’s patients who completed their course…
Share this Post
More Posts
A ‘Ring Strategy’ for Bird Flu
(MedPage Today) — Six years after the COVID pandemic began, we are still locked in three of the five stages of a so-called typical response to a pandemic, as described in a recent opinion article. Those three stages are: Ignore and deny (stage…
Abortion Opponents Want Trump’s FDA to Act on Mifepristone Restrictions
(MedPage Today) — U.S. abortion opponents are increasingly frustrated with the lack of action by President Donald Trump’s administration to stem the flow of abortion pills prescribed online that they view as undermining state abortion bans.
A…
Unusual airborne toxin detected in the U.S. for the first time
Scientists searching for air pollution clues stumbled onto something unexpected: toxic MCCPs drifting through the air for the first time
